ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

N,N-Dimethylglycine → 1-[4-[4-Amino-5-(5-fluoro-2-methoxy-benzoyl)-pyrimidin-2-ylamino]-piperidin-1-yl]-2-dimethylamino-ethanone

HRID 1371631
印刷

反応式

HRID 1371631 の反応式
[CH3:1][N:2]([CH2:4][C:5]([OH:7])=O)[CH3:3].O.ON1C2C=CC=CC=2N=N1.F[P-](F)(F)(F)(F)F.N1(OC(N(C)C)=[N+](C)C)C2C=CC=CC=2N=N1.FC(F)(F)C(O)=O.[NH2:50][C:51]1[C:56]([C:57]([C:59]2[CH:64]=[C:63]([F:65])[CH:62]=[CH:61][C:60]=2[O:66][CH3:67])=[O:58])=[CH:55][N:54]=[C:53]([NH:68][CH:69]2[CH2:74][CH2:73][NH:72][CH2:71][CH2:70]2)[N:52]=1.C(N(CC)CC)C>CN(C)C=O>[NH2:50][C:51]1[C:56]([C:57](=[O:58])[C:59]2[CH:64]=[C:63]([F:65])[CH:62]=[CH:61][C:60]=2[O:66][CH3:67])=[CH:55][N:54]=[C:53]([NH:68][CH:69]2[CH2:74][CH2:73][N:72]([C:5](=[O:7])[CH2:4][N:2]([CH3:3])[CH3:1])[CH2:71][CH2:70]2)[N:52]=1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 5

HCID 673N,N-DimethylglycineHCID 8471TriethylamineHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 27960291-Hydroxybenzotriazole hydrateHCID 21070627[4-Amino-2-(piperidin4-ylamino)-pyrimidin-5-yl]-(5-fluoro-2-methoxy-phenyl)-methanone trifluoroacetic acid salt

生成物 1

HCID 10320478
1-[4-[4-Amino-5-(5-fluoro-2-methoxy-benzoyl)-pyrimidin-2-ylamino]-piperidin-1-yl]-2-dimethylamino-ethanone
収率 30.6%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒2 回

実験手順

To a solution of N,N-dimethylaminoacetic acid (9.8 mg, 0.095 mmol, Aldrich) in dimethylformamide (2 mL) were added 1-hydroxybenzotriazole hydrate (16.5 mg, 0.108 mmol, Aldrich), O-benzotriazol-1-yl-N,N,N′,N′-tetramethyluronium hexafluorophosphate (40.8 mg, 0.108 mmol, Aldrich). After it was stirred for 20 minutes, a solution of [4-amino-2-(piperidin-4-ylamino)-pyrimidin-5-yl]-(5-fluoro-2-methoxy-phenyl)-methanone trifluoroacetic acid salt (47 mg, Example 59) and triethylamine (47 mg, 0.469 mmol, Aldrich) in dimethylformamide (2 mL) were added. The mixture was stirred overnight at room temperature before it was concentrated, taken up in ethyl acetate, washed with brine and evaporated. The crude product was purified on HPLC to give 1-[4-[4-amino-5-(5-fluoro-2-methoxy-benzoyl)-pyrimidin-2-ylamino]-piperidin-1-yl]-2-dimethylamino-ethanone (12.5 mg). MS (M+H)+: 431.

後処理

  1. stirringThe mixture was stirred overnight at room temperature before it
  2. concentrationwas concentrated
  3. washwashed with brine
  4. customevaporated
  5. customThe crude product was purified on HPLC

出典と根拠

ORDレコード
ord-4d180ec2d2e048b08c8cf227a59f28d2
出典データセット
uspto-grants-2007_01
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07157455B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート